COVID-19 has been pretty disruptive on clinical-level biotech and pharmaceutical companies worldwide, especially those running on tight budgets. Clinical trials…
Hasbro, Inc. (NASDAQ: HAS) on Wednesday reported first-quarter 2020 financial results. Notably, it was the first announcement after the integration of…